Specialists Encouraged to Use Cenobamate: A Highly Effective Anti-Seizure Medication for Epilepsy Treatment
Bernhard J. Steinhoff, from the Adult Department at the Kork Epilepsy Center in Kehl-Kork, Germany, presents clinical recommendations for therapeutic strategies during cenobamate treatment initiation in this MEDtalk. These recommendations, developed by a European consensus Delphi panel chaired by Steinhoff, address the complexities of cenobamates’ pharmacokinetic and dynamic profile. Given that U.S. guidelines are not always applicable in Europe due to differing labeling, this guidance is tailored to the European context. Steinhoff highlights that cenobamate is an exceptionally powerful anti-seizure medication for patients with epilepsy.
Få tillgång
Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.
- Få tillgång
- Om du redan har en profil: Logga in